Ovalis, a Mountain View, Calif. developer of catheter-based products for repairing cardiac defects, has raised around $6.6 million in Series B funding, according to a regulatory filing cited by PE Week. Return backers include Abbott Labs, De Novo Ventures and Latterell Venture Partners.

(Originally posted 1/16)